ATE142884T1 - Verwendung von magnesium-pyridoxal-5'-phosphat- glutaminat zur verhinderung von krankheiten verursacht durch gefässläsionen - Google Patents
Verwendung von magnesium-pyridoxal-5'-phosphat- glutaminat zur verhinderung von krankheiten verursacht durch gefässläsionenInfo
- Publication number
- ATE142884T1 ATE142884T1 AT91108217T AT91108217T ATE142884T1 AT E142884 T1 ATE142884 T1 AT E142884T1 AT 91108217 T AT91108217 T AT 91108217T AT 91108217 T AT91108217 T AT 91108217T AT E142884 T1 ATE142884 T1 AT E142884T1
- Authority
- AT
- Austria
- Prior art keywords
- glutaminate
- phosphate
- vascular lesions
- diseases caused
- preventing diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4016963A DE4016963A1 (de) | 1990-05-25 | 1990-05-25 | Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE142884T1 true ATE142884T1 (de) | 1996-10-15 |
Family
ID=6407228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91108217T ATE142884T1 (de) | 1990-05-25 | 1991-05-22 | Verwendung von magnesium-pyridoxal-5'-phosphat- glutaminat zur verhinderung von krankheiten verursacht durch gefässläsionen |
Country Status (28)
Country | Link |
---|---|
US (1) | US5372999A (de) |
EP (1) | EP0458287B1 (de) |
JP (1) | JPH07119174B2 (de) |
KR (1) | KR970005180B1 (de) |
CN (1) | CN1050750C (de) |
AT (1) | ATE142884T1 (de) |
AU (1) | AU651108B2 (de) |
CA (1) | CA2043228C (de) |
CZ (1) | CZ280683B6 (de) |
DE (2) | DE4016963A1 (de) |
DK (1) | DK0458287T3 (de) |
EG (1) | EG19730A (de) |
ES (1) | ES2091262T3 (de) |
GR (1) | GR3021077T3 (de) |
HR (1) | HRP931445B1 (de) |
HU (1) | HU219223B (de) |
IE (1) | IE76728B1 (de) |
IL (1) | IL98156A (de) |
IN (1) | IN173057B (de) |
LT (1) | LT3335B (de) |
LV (1) | LV10046B (de) |
MD (1) | MD306C2 (de) |
MX (1) | MX171883B (de) |
RU (1) | RU2041713C1 (de) |
SI (1) | SI9110925A (de) |
SK (1) | SK278896B6 (de) |
UA (1) | UA26973A1 (de) |
ZA (1) | ZA913692B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19527820A1 (de) * | 1995-07-28 | 1997-01-30 | Leniger Follert Elfriede Prof | Arzneimittel zur Behandlung von Ulcera, insbesondere bei arteriellen und venösen Durchblutungsstörungen der Extremitäten, bei chronisch venöser Insuffizienz und Lymphödem |
DE19532625C2 (de) * | 1995-09-04 | 2000-04-20 | Steigerwald Arzneimittelwerk | Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
EP1169322B8 (de) | 1999-03-08 | 2006-09-13 | Medicure Inc. | Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel |
WO2001003682A2 (en) * | 1999-07-13 | 2001-01-18 | Medicure Inc. | Use of pyridoxin derivatives for the treatment of diabetes and related complications |
EP1872797A3 (de) * | 1999-08-24 | 2008-04-02 | Medicure International Inc. | Behandlung kardiovaskulärer und verwandter Leiden |
US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
DE60110054T2 (de) | 2000-02-29 | 2006-03-09 | Medicure International Inc. | Cardioprotektive phosphonate |
EP1278526A2 (de) | 2000-03-28 | 2003-01-29 | Medicure International Inc. | Behandlung von zerebrovaskulären erkrankungen |
US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
ATE364595T1 (de) | 2000-07-07 | 2007-07-15 | Medicure Int Inc | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika |
US6897228B2 (en) | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
US7812037B2 (en) | 2004-10-28 | 2010-10-12 | Medicure International, Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
US7459468B2 (en) | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
CA2680801A1 (en) | 2007-03-14 | 2008-09-18 | Sierra Molecular Corporation | Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule |
RU2484843C1 (ru) * | 2012-04-03 | 2013-06-20 | Алексей Кириллович Пехтерев | Лекарственный сбор растений для лечения сердечно-сосудистых заболеваний |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE246172C (de) | ||||
DE2461742C2 (de) * | 1974-12-28 | 1983-01-27 | Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt | Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE3807895A1 (de) * | 1988-03-10 | 1989-09-21 | Knoll Ag | Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker |
-
1990
- 1990-05-25 DE DE4016963A patent/DE4016963A1/de active Granted
-
1991
- 1991-05-13 IN IN362CA1991 patent/IN173057B/en unknown
- 1991-05-15 ZA ZA913692A patent/ZA913692B/xx unknown
- 1991-05-16 IL IL9815691A patent/IL98156A/en active IP Right Grant
- 1991-05-22 DE DE69122170T patent/DE69122170T2/de not_active Expired - Fee Related
- 1991-05-22 KR KR1019910008233A patent/KR970005180B1/ko not_active IP Right Cessation
- 1991-05-22 EP EP91108217A patent/EP0458287B1/de not_active Expired - Lifetime
- 1991-05-22 EG EG32091A patent/EG19730A/xx active
- 1991-05-22 DK DK91108217.0T patent/DK0458287T3/da active
- 1991-05-22 ES ES91108217T patent/ES2091262T3/es not_active Expired - Lifetime
- 1991-05-22 AT AT91108217T patent/ATE142884T1/de not_active IP Right Cessation
- 1991-05-23 SI SI9110925A patent/SI9110925A/sl unknown
- 1991-05-24 HU HU756/91A patent/HU219223B/hu not_active IP Right Cessation
- 1991-05-24 SK SK1563-91A patent/SK278896B6/sk unknown
- 1991-05-24 AU AU77301/91A patent/AU651108B2/en not_active Ceased
- 1991-05-24 CZ CS911563A patent/CZ280683B6/cs not_active IP Right Cessation
- 1991-05-24 RU SU914895539A patent/RU2041713C1/ru active
- 1991-05-24 MX MX025919A patent/MX171883B/es unknown
- 1991-05-24 JP JP3149739A patent/JPH07119174B2/ja not_active Expired - Lifetime
- 1991-05-24 IE IE178391A patent/IE76728B1/en not_active IP Right Cessation
- 1991-05-24 UA UA4895539A patent/UA26973A1/uk unknown
- 1991-05-24 CA CA002043228A patent/CA2043228C/en not_active Expired - Fee Related
- 1991-05-25 CN CN91104365A patent/CN1050750C/zh not_active Expired - Fee Related
-
1993
- 1993-04-02 US US08/041,896 patent/US5372999A/en not_active Expired - Fee Related
- 1993-05-14 LV LVP-93-343A patent/LV10046B/en unknown
- 1993-05-31 LT LTIP580A patent/LT3335B/lt not_active IP Right Cessation
- 1993-11-26 HR HRP-925/91A patent/HRP931445B1/xx not_active IP Right Cessation
-
1994
- 1994-11-25 MD MD94-0391A patent/MD306C2/ro active IP Right Grant
-
1996
- 1996-09-19 GR GR960402156T patent/GR3021077T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE142884T1 (de) | Verwendung von magnesium-pyridoxal-5'-phosphat- glutaminat zur verhinderung von krankheiten verursacht durch gefässläsionen | |
DE59310327D1 (de) | Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura | |
ES2095380T3 (es) | Derivados de indano-2-carboxialquilo sustituidos en la posicion 2 utiles como inhibidores de la encefalinasa y la eca. | |
EP0363415A4 (en) | Compounds for the treatment of alzheimer's disease | |
ATE135208T1 (de) | Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen | |
DE69600084D1 (de) | Verwendung von hydroxylierte Carbonsäure zur Behandlung von Nägeln | |
ATE83378T1 (de) | Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen. | |
DE69420776D1 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
LV12251A (lv) | 2-fenil-1,2-benzizoseleazol-3(2h)-ona pielietojums medikamenta razosanai kas paredzets alcheimera slimibas profilaksei un/vai terapijai | |
ATE77560T1 (de) | Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen. | |
ATE227557T1 (de) | Verwendung von zahnpflegemitteln enthaltend bovines kolostrum | |
DE69207885D1 (de) | Gammalinolensäure zur Herstellung eines Medikaments zur Verhinderung von Wiederverschluss von Arterien | |
ATE229336T1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
DE69124415D1 (de) | Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen | |
DE50003730D1 (de) | Caspase 8-inhibitoren zur immunsuppression | |
DE59410340D1 (de) | Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen | |
ATE213955T1 (de) | Verminderung des fettgewebes durch verwendung von kollagenase | |
ATE315583T1 (de) | Analoge des thymosin alpha 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |